SCHEMBL5089556

SCHEMBL5089556

CCCCCCC#CC=CC#Cc1ccccc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.40
TSHR P16473 1/20 0.40
KCNH2 Q12809 2/20 0.38
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
ALOX12 P18054 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
FFAR1 O14842 2/20 0.36
CYSLTR2 Q9NS75 1/20 0.35
CYSLTR1 Q9Y271 1/20 0.35
HMGCR P04035 2/20 0.34
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
EPHX2 P34913 1/20 0.32
MMP2 P08253 1/20 0.32
MMP12 P39900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5089552 1.00 CYP3A4 (0.40) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL5092715 0.78 CYP3A4 (0.38) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL5092707 0.78 CYP3A4 (0.38) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL5095222 0.77 FFAR1 (0.40) CYP3A4TSHRKCNH2FFAR1HMGCR
SCHEMBL5095221 0.77 FFAR1 (0.40) CYP3A4TSHRKCNH2FFAR1HMGCR
SCHEMBL5095145 0.75 HMGCR (0.44) CYP3A4TSHRMAPTKDM4EALDH1A1
SCHEMBL5095139 0.75 HMGCR (0.44) CYP3A4TSHRMAPTKDM4EALDH1A1
SCHEMBL5092667 0.75 FFAR1 (0.48) CYP3A4TSHRKCNH2FFAR1HMGCR
SCHEMBL5092657 0.75 FFAR1 (0.48) CYP3A4TSHRKCNH2FFAR1HMGCR
SCHEMBL5092655 0.74 GRM5 (0.40) KCNH2FFAR1FFAR4TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332623-B2 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2008-02-19 US disclosed
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds CCNI, TOP1, TOP2B CYP3A4 542/4885TSHR 1305/4885KCNH2 1925/4885
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds CCNI, TOP2B, TOP2A CYP3A4 1065/4885TSHR 730/4885KCNH2 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.